BMS in US$4.8B KRAS buy

By Megan Brodie 3 years ago | In Companies
  • 3 years ago

9 October 2023 BMS is to acquire Mirati Therapeutics for a total equity value of…

This is subscriber-only content. Please login to continue reading.

Recent News

Top Reads